{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:09:51Z","timestamp":1778573391431,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["MA 1053\/7-1"],"award-info":[{"award-number":["MA 1053\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008848","name":"Elite Network of Bavaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nmd.2025.105345","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:07:09Z","timestamp":1743008829000},"page":"105345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic sphingosine-1-phosphate receptor modulation by repurposing fingolimod (FTY720) leads to mitigated neuropathy and improved clinical outcome in a mouse model for Charcot-Marie-Tooth 1X disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Xidi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-445X","authenticated-orcid":false,"given":"Dennis","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.105345_bib0001","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2015.11.033","article-title":"Myelin and macrophages in the PNS: an intimate relationship in trauma and disease","volume":"1641","author":"Klein","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.nmd.2025.105345_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jns.12539","article-title":"Recent advances in the treatment of Charcot-Marie-Tooth neuropathies","volume":"28","author":"Bolino","year":"2023","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2025.105345_bib0003","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/brain\/awv240","article-title":"Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice","volume":"138","author":"Klein","year":"2015","journal-title":"Brain: J Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/glia.24158","article-title":"Early targeting of endoneurial macrophages alleviates the neuropathy and affects abnormal Schwann cell differentiation in a mouse model of Charcot-Marie-Tooth 1A","volume":"70","author":"Klein","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.nmd.2025.105345_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114195","article-title":"Presymptomatic macrophage targeting has a long-lasting therapeutic effect on treatment termination in a mouse model of Charcot-Marie-Tooth 1","volume":"357","author":"Ostertag","year":"2022","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0006","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/glia.22796","article-title":"CSF-1-activated macrophages are target-directed and essential mediators of schwann cell dedifferentiation and dysfunction in Cx32-deficient mice","volume":"63","author":"Groh","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.nmd.2025.105345_bib0007","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/brain\/awg072","article-title":"Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1","volume":"126","author":"Kobsar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2025.105345_bib0008","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cei.12195","article-title":"Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies","volume":"175","author":"Melzer","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nmd.2025.105345_bib0009","article-title":"Immune therapy of Multiple sclerosis - future strategies","author":"Meuth","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nmd.2025.105345_bib0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nmd.2025.105345_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106698","article-title":"Cytotoxic CNS-associated T cells drive axon degeneration by targeting perturbed oligodendrocytes in PLP1 mutant mice","volume":"26","author":"Abdelwahab","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.nmd.2025.105345_bib0012","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","article-title":"Fingolimod and teriflunomide attenuate neurodegeneration in mouse models of neuronal ceroid lipofuscinosis","volume":"25","author":"Groh","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2025.105345_bib0013","doi-asserted-by":"crossref","first-page":"fcab047","DOI":"10.1093\/braincomms\/fcab047","article-title":"Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset","volume":"3","author":"Groh","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.nmd.2025.105345_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114119","article-title":"CNS-associated T-lymphocytes in a mouse model of Hereditary Spastic Paraplegia type 11 (SPG11) are therapeutic targets for established immunomodulators","volume":"355","author":"Horner","year":"2022","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0015","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1523\/JNEUROSCI.17-12-04545.1997","article-title":"Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32","volume":"17","author":"Anzini","year":"1997","journal-title":"J Neurosci: Offic J Society Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0016","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1073\/pnas.93.18.9565","article-title":"Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice","volume":"93","author":"Nelles","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2025.105345_bib0017","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/hmg\/ddq269","article-title":"Attenuation of MCP-1\/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X","volume":"19","author":"Groh","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2025.105345_bib0018","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/hmg\/ddz199","article-title":"Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X","volume":"28","author":"Kagiava","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2025.105345_bib0019","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1523\/JNEUROSCI.3427-15.2016","article-title":"Cell-surface and secreted isoforms of CSF-1 exert opposing roles in macrophage-mediated neural damage in Cx32-deficient mice","volume":"36","author":"Groh","year":"2016","journal-title":"J Neurosci: Offic J Society Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0020","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1523\/JNEUROSCI.3030-17.2018","article-title":"Macrophage depletion ameliorates peripheral neuropathy in aging mice","volume":"38","author":"Yuan","year":"2018","journal-title":"J Neurosci: Offic J Society Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/jns.12669","article-title":"Physical exercise halts further functional decline in an animal model for Charcot-Marie-Tooth disease 1X at an advanced disease stage","author":"Klein","year":"2024","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2025.105345_bib0022","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8","article-title":"Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations","volume":"19","author":"Zielasek","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105345_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113786","article-title":"Physical exercise mitigates neuropathic changes in an animal model for Charcot-Marie-Tooth disease 1X","volume":"343","author":"Klein","year":"2021","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0024","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.nmd.2025.105345_bib0025","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis","volume":"1","author":"Gonzalez-Lorenzo","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2025.105345_bib0026","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1056\/NEJMoa1800149","article-title":"Trial of Fingolimod versus Interferon beta-1a in pediatric Multiple sclerosis","volume":"379","author":"Chitnis","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2025.105345_bib0027","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1523\/JNEUROSCI.20-02-00729.2000","article-title":"Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance","volume":"20","author":"Schmid","year":"2000","journal-title":"J Neurosci: Offic J Society Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0028","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1006\/mcne.2001.0990","article-title":"Bone marrow transfer from wild type mice reverts the beneficial effect of genetically-mediated immune deficiency in myelin mutants","volume":"17","author":"M\u00e4urer","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0029","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s43587-021-00049-z","article-title":"Accumulation of cytotoxic T cells in the aged CNS leads to axon degeneration and contributes to cognitive and motor decline","volume":"1","author":"Groh","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.nmd.2025.105345_bib0030","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1038\/s41467-023-42570-2","article-title":"Microglia-mediated demyelination protects against CD8(+) T cell-driven axon degeneration in mice carrying PLP defects","volume":"14","author":"Groh","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2025.105345_bib0031","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/glia.23162","article-title":"Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: understanding pathogenesis and chances for treatment","volume":"65","author":"Groh","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.nmd.2025.105345_bib0032","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41593-020-0618-6","article-title":"Profiling peripheral nerve macrophages reveals two macrophage subsets with distinct localization, transcriptome and response to injury","volume":"23","author":"Ydens","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0033","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/s41467-020-16355-w","article-title":"Peripheral nerve resident macrophages share tissue-specific programming and features of activated microglia","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2025.105345_bib0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4049\/jimmunol.1901077","article-title":"Origin and differentiation of nerve-associated macrophages","volume":"204","author":"Kolter","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2025.105345_bib0035","first-page":"129","article-title":"Sheaths of the spinal nerve roots. Permeability and structural characteristics of dorsal and ventral spinal nerve roots of the rat","volume":"85","author":"Pettersson","year":"1993","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2025.105345_bib0036","first-page":"137","article-title":"The sheaths surrounding the attachments of rat lumbar ventral roots to the spinal cord: a light and electron microscopical study","volume":"148","author":"Kaar","year":"1986","journal-title":"J Anat"},{"key":"10.1016\/j.nmd.2025.105345_bib0037","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.1999.tb00231.x","article-title":"Mechanisms of immune regulation in the peripheral nervous system","volume":"9","author":"Gold","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nmd.2025.105345_bib0038","first-page":"1905","volume":"8","author":"Schetters","year":"2017","journal-title":"Neuroinflammation: Microglia T Cells Get Ready Tango. Front Immunol"},{"key":"10.1016\/j.nmd.2025.105345_bib0039","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/glia.22962","article-title":"Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease","volume":"64","author":"Groh","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.nmd.2025.105345_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2006.08.023","article-title":"Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice","volume":"25","author":"Ip","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2025.105345_bib0041","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","article-title":"The direct effects of Fingolimod in the Central nervous system: implications for relapsing multiple sclerosis","volume":"30","author":"Hunter","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nmd.2025.105345_bib0042","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2015.05.002","article-title":"Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype","volume":"271","author":"Heinen","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0043","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1096\/fj.201801799R","article-title":"Secretome analysis of nerve repair mediating Schwann cells reveals Smad-dependent trophism","volume":"33","author":"Schira","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2025.105345_bib0044","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-016-0612-9","article-title":"Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling","volume":"13","author":"Szepanowski","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nmd.2025.105345_bib0045","article-title":"Effects of sphingosine-1-phosphate on the facilitation of peripheral nerve regeneration","volume":"16","author":"Li","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.nmd.2025.105345_bib0046","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2016.03.012","article-title":"The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration","volume":"279","author":"Anastasiadou","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0047","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2010.01.001","article-title":"Lack of evidence for a pathogenic role of T-lymphocytes in an animal model for Charcot-Marie-Tooth disease 1A","volume":"38","author":"Kohl","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2025.105345_bib0048","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mcn.2003.09.015","article-title":"Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants","volume":"25","author":"Ulzheimer","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0049","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/brain\/awr283","article-title":"Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X","volume":"135","author":"Groh","year":"2012","journal-title":"Brain: J Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.nbd.2016.05.014","article-title":"Progression of motor axon dysfunction and ectopic Na1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B","volume":"93","author":"Rosberg","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2025.105345_bib0051","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/01.wnl.0000256709.08271.4d","article-title":"CMT1X phenotypes represent loss of GJB1 gene function","volume":"68","author":"Shy","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105345_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/srep40166","article-title":"Loss of coupling distinguishes GJB1 mutations associated with CNS manifestations of CMT1X from those without CNS manifestations","volume":"7","author":"Abrams","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2025.105345_bib0053","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2012.03.068","article-title":"How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?","volume":"1487","author":"Kleopa","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.nmd.2025.105345_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114277","article-title":"Knock-in mouse models for CMTX1 show a loss of function phenotype in the peripheral nervous system","volume":"360","author":"Abrams","year":"2023","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0055","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1523\/JNEUROSCI.0325-09.2009","article-title":"Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects","volume":"29","author":"Sargiannidou","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.nmd.2025.105345_bib0056","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jns.12588","article-title":"Two new mouse models of Gjb1-associated Charcot-Marie-Tooth disease type 1X","volume":"28","author":"Tadenev","year":"2023","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2025.105345_bib0057","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00441-014-2014-6","article-title":"GJB1-associated X-linked Charcot-Marie-Tooth disease, a disorder affecting the central and peripheral nervous systems","volume":"360","author":"Abrams","year":"2015","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.nmd.2025.105345_bib0058","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/hmg\/ddy056","article-title":"Intrathecal gene therapy in mouse models expressing CMT1X mutations","volume":"27","author":"Kagiava","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2025.105345_bib0059","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(04)00822-1","article-title":"Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients","volume":"3","author":"Martini","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105345_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijms26010015","article-title":"A role of inflammation in Charcot\u2013Marie\u2013Tooth disorders\u2014In a perspective of treatment?","volume":"26","author":"Kami\u0144ska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.105345_bib0061","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab047","article-title":"Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset","volume":"3","author":"Groh","year":"2021","journal-title":"Brain Comm"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:41Z","timestamp":1778570561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":61,"alternative-id":["S0960896625000720"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105345","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic sphingosine-1-phosphate receptor modulation by repurposing fingolimod (FTY720) leads to mitigated neuropathy and improved clinical outcome in a mouse model for Charcot-Marie-Tooth 1X disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105345"}}